Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 12q14 Microdeletion Syndrome C4305140
Clinical comparison between 2p13 2 Microdeletion Syndrome and 12q14 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
12q14 Microdeletion Syndrome C4305140
A rare genetic deletion involving a segment of chromosome 12. It may lead to developmental delays, learning difficulties, and other health issues. Management is individualized and focuses on supportive therapies.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
12q14 Microdeletion Syndrome C4305140
0-2
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
12q14 Microdeletion Syndrome C4305140
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
12q14 Microdeletion Syndrome C4305140
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
12q14 Microdeletion Syndrome C4305140
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
12q14 Microdeletion Syndrome C4305140
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
12q14 Microdeletion Syndrome C4305140
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 12q14-microdeletion-syndrome-C4305140 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 12q14 Microdeletion Syndrome C4305140 | Discriminating power |
|---|---|---|---|
| Developmental concerns | Features vary; developmental effects are not specified in the source. | May include developmental delay and learning difficulty. | Moderate |
| Overall clinical severity | Labeled severe, but exact manifestations are not defined. | Labeled moderate, with individualized supportive needs. | Low |
| Age at recognition | Source onset window is at birth (0–0). | Source onset window is birth to age 2 years. | Moderate |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
A chromosomal microarray shows a deletion at 2p13.2
The locus, not symptoms alone, identifies this condition.
High
Congenital findings are present from birth
This fits the supplied onset window, but is not specific.
Low
Severe multisystem effects need coordinated care
Severity is labeled severe, although exact complications are unestablished.
Low
Choose 12q14 Microdeletion Syndrome C4305140 when
Testing confirms a deletion involving 12q14
Genetic locus confirmation distinguishes it from 2p13.2 deletion.
High
Developmental delay or learning difficulty appears by age 2
These are the only clinical features stated for this condition.
Moderate
Supportive therapy needs appear moderate rather than severe
This matches the supplied severity label but does not prove the diagnosis.
Low
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 12q14 Microdeletion Syndrome C4305140 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a small deletion at 2p13.2. | May detect a deletion involving 12q14. | The reported locus distinguishes the conditions; clinician and laboratory review is required. |
| Standard karyotype | A small deletion may be missed. | A small deletion may also be missed. | A normal karyotype does not exclude either microdeletion. |
| Clinical examination | Variable findings; no definitive pattern is supplied. | Possible developmental or learning concerns; pattern not fully defined. | Examination cannot reliably separate these diagnoses. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; the source labels severity as severe.
- Factors
- Affected genes and individual symptoms may influence needs.
12q14 Microdeletion Syndrome C4305140
- Outcome
- Outcome is not established; developmental and learning effects may occur.
- Factors
- Supportive therapies and individual health issues may influence function.
Time frame: Both are described as chronic, without a defined prognosis interval.
No mortality, prevalence, or outcome rates are supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Possible but not specifically established. Developmental delay is described as possible. Extent and permanence are not established from the supplied data. |
| Learning difficulty | Not specifically stated. Listed as a possible feature. Educational assessment should be individualized. |
| Other health issues | May occur depending on affected genes. Other issues are mentioned without specifics. No complication rates or definitive organ findings are supplied. |
Patient education highlights
- HighDiagnosis
These are chromosomal findings confirmed by genetic testing, not by symptoms alone.
- HighVariability
Features can differ widely; sparse source data do not define a typical course.
- MediumCare
Management is supportive and individualized; no treatment dose is established here.